174 related articles for article (PubMed ID: 18991284)
1. A Griscelli syndrome type 2 murine model of hemophagocytic lymphohistiocytosis (HLH).
Pachlopnik Schmid J; Ho CH; Diana J; Pivert G; Lehuen A; Geissmann F; Fischer A; de Saint Basile G
Eur J Immunol; 2008 Nov; 38(11):3219-25. PubMed ID: 18991284
[TBL] [Abstract][Full Text] [Related]
2. The risk of hemophagocytic lymphohistiocytosis in Hermansky-Pudlak syndrome type 2.
Jessen B; Bode SF; Ammann S; Chakravorty S; Davies G; Diestelhorst J; Frei-Jones M; Gahl WA; Gochuico BR; Griese M; Griffiths G; Janka G; Klein C; Kögl T; Kurnik K; Lehmberg K; Maul-Pavicic A; Mumford AD; Pace D; Parvaneh N; Rezaei N; de Saint Basile G; Schmitt-Graeff A; Schwarz K; Karasu GT; Zieger B; Zur Stadt U; Aichele P; Ehl S
Blood; 2013 Apr; 121(15):2943-51. PubMed ID: 23403622
[TBL] [Abstract][Full Text] [Related]
3. Distinct severity of HLH in both human and murine mutants with complete loss of cytotoxic effector PRF1, RAB27A, and STX11.
Sepulveda FE; Debeurme F; Ménasché G; Kurowska M; Côte M; Pachlopnik Schmid J; Fischer A; de Saint Basile G
Blood; 2013 Jan; 121(4):595-603. PubMed ID: 23160464
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effect of JAK1/2 blockade on the manifestations of hemophagocytic lymphohistiocytosis in mice.
Maschalidi S; Sepulveda FE; Garrigue A; Fischer A; de Saint Basile G
Blood; 2016 Jul; 128(1):60-71. PubMed ID: 27222478
[TBL] [Abstract][Full Text] [Related]
5. Neutralization of IFNgamma defeats haemophagocytosis in LCMV-infected perforin- and Rab27a-deficient mice.
Pachlopnik Schmid J; Ho CH; Chrétien F; Lefebvre JM; Pivert G; Kosco-Vilbois M; Ferlin W; Geissmann F; Fischer A; de Saint Basile G
EMBO Mol Med; 2009 May; 1(2):112-24. PubMed ID: 20049711
[TBL] [Abstract][Full Text] [Related]
6. Novel RAB27A Variant Associated with Late-Onset Hemophagocytic Lymphohistiocytosis Alters Effector Protein Binding.
Zondag TCE; Torralba-Raga L; Van Laar JAM; Hermans MAW; Bouman A; Hollink IHIM; Van Hagen PM; Briggs DA; Hume AN; Bryceson YT
J Clin Immunol; 2022 Nov; 42(8):1685-1695. PubMed ID: 35870028
[TBL] [Abstract][Full Text] [Related]
7. Patients with Griscelli syndrome and normal pigmentation identify RAB27A mutations that selectively disrupt MUNC13-4 binding.
Cetica V; Hackmann Y; Grieve S; Sieni E; Ciambotti B; Coniglio ML; Pende D; Gilmour K; Romagnoli P; Griffiths GM; Aricò M
J Allergy Clin Immunol; 2015 May; 135(5):1310-8.e1. PubMed ID: 25312756
[TBL] [Abstract][Full Text] [Related]
8. Griscelli Syndrome Type 2 Sine Albinism: Unraveling Differential RAB27A Effector Engagement.
Ohishi Y; Ammann S; Ziaee V; Strege K; Groß M; Amos CV; Shahrooei M; Ashournia P; Razaghian A; Griffiths GM; Ehl S; Fukuda M; Parvaneh N
Front Immunol; 2020; 11():612977. PubMed ID: 33362801
[TBL] [Abstract][Full Text] [Related]
9. Rapamycin does not control hemophagocytic lymphohistiocytosis in LCMV-infected perforin-deficient mice.
Rothman JA; Das R; Teachey DT; Paessler ME; Nichols KE
Pediatr Blood Cancer; 2011 Dec; 57(7):1239-43. PubMed ID: 21681935
[TBL] [Abstract][Full Text] [Related]
10. Polygenic mutations in the cytotoxicity pathway increase susceptibility to develop HLH immunopathology in mice.
Sepulveda FE; Garrigue A; Maschalidi S; Garfa-Traore M; Ménasché G; Fischer A; de Saint Basile G
Blood; 2016 Apr; 127(17):2113-21. PubMed ID: 26864340
[TBL] [Abstract][Full Text] [Related]
11. Mouse Cytomegalovirus Infection in BALB/c Mice Resembles Virus-Associated Secondary Hemophagocytic Lymphohistiocytosis and Shows a Pathogenesis Distinct from Primary Hemophagocytic Lymphohistiocytosis.
Brisse E; Imbrechts M; Put K; Avau A; Mitera T; Berghmans N; Rutgeerts O; Waer M; Ninivaggi M; Kelchtermans H; Boon L; Snoeck R; Wouters CH; Andrei G; Matthys P
J Immunol; 2016 Apr; 196(7):3124-34. PubMed ID: 26903481
[TBL] [Abstract][Full Text] [Related]
12. IL-2 consumption by highly activated CD8 T cells induces regulatory T-cell dysfunction in patients with hemophagocytic lymphohistiocytosis.
Humblet-Baron S; Franckaert D; Dooley J; Bornschein S; Cauwe B; Schönefeldt S; Bossuyt X; Matthys P; Baron F; Wouters C; Liston A
J Allergy Clin Immunol; 2016 Jul; 138(1):200-209.e8. PubMed ID: 26947179
[TBL] [Abstract][Full Text] [Related]
13. Janus kinase inhibition lessens inflammation and ameliorates disease in murine models of hemophagocytic lymphohistiocytosis.
Das R; Guan P; Sprague L; Verbist K; Tedrick P; An QA; Cheng C; Kurachi M; Levine R; Wherry EJ; Canna SW; Behrens EM; Nichols KE
Blood; 2016 Mar; 127(13):1666-75. PubMed ID: 26825707
[TBL] [Abstract][Full Text] [Related]
14. IFN-γ and CD25 drive distinct pathologic features during hemophagocytic lymphohistiocytosis.
Humblet-Baron S; Franckaert D; Dooley J; Ailal F; Bousfiha A; Deswarte C; Oleaga-Quintas C; Casanova JL; Bustamante J; Liston A
J Allergy Clin Immunol; 2019 Jun; 143(6):2215-2226.e7. PubMed ID: 30578871
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of action of ruxolitinib in murine models of hemophagocytic lymphohistiocytosis.
Albeituni S; Verbist KC; Tedrick PE; Tillman H; Picarsic J; Bassett R; Nichols KE
Blood; 2019 Jul; 134(2):147-159. PubMed ID: 31015190
[TBL] [Abstract][Full Text] [Related]
16. Evidence for defective Rab GTPase-dependent cargo traffic in immune disorders.
Krzewski K; Cullinane AR
Exp Cell Res; 2013 Sep; 319(15):2360-7. PubMed ID: 23810987
[TBL] [Abstract][Full Text] [Related]
17. ST2 contributes to T-cell hyperactivation and fatal hemophagocytic lymphohistiocytosis in mice.
Rood JE; Rao S; Paessler M; Kreiger PA; Chu N; Stelekati E; Wherry EJ; Behrens EM
Blood; 2016 Jan; 127(4):426-35. PubMed ID: 26518437
[TBL] [Abstract][Full Text] [Related]
18. Trigger-dependent differences determine therapeutic outcome in murine primary hemophagocytic lymphohistiocytosis.
Gather R; Aichele P; Goos N; Rohr J; Pircher H; Kögl T; Zeiser R; Hengel H; Schmitt-Gräff A; Weaver C; Ehl S
Eur J Immunol; 2020 Nov; 50(11):1770-1782. PubMed ID: 32419134
[TBL] [Abstract][Full Text] [Related]
19. Successful rescue of a lethal Griscelli syndrome type 2 presenting with neurological involvement and hemophagocytic lymphohistiocytosis: a case report.
Zhang Q; Zhao YZ; Ma HH; Wang D; Zhang N; Li ZG; Zhang R
BMC Pediatr; 2021 May; 21(1):253. PubMed ID: 34058999
[TBL] [Abstract][Full Text] [Related]
20. The leaden gene product is required with Rab27a to recruit myosin Va to melanosomes in melanocytes.
Hume AN; Collinson LM; Hopkins CR; Strom M; Barral DC; Bossi G; Griffiths GM; Seabra MC
Traffic; 2002 Mar; 3(3):193-202. PubMed ID: 11886590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
